Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial.

Kidney Int · 2015 · PMC4449803 · PMID 25651367

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep=.10so close (0.05 < p ≤ 0.1)

Data examining the subset with and without CKD separately are shown in Table 5 In participants with CKD, there was a 3.3% (24.2%) improvement in eGFR from baseline to year 3 in those randomized to placebo, whereas there was a 1.8% (22.3%) decrease in those randomized to ERN, a result that did not reach statistical significance (p=.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.